MannKind Cash Flow Statement
NASDAQ: MNKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MannKind free cash flow
In fiscal 2025, MannKind generated $18.3 million of operating cash flow and spent $4.6 million on capital expenditures. That left free cash flow of $13.7 million, a free-cash-flow margin of 3.9% of revenue. Free cash flow was down 58.3% from the prior year's $32.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
MannKind cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 5.86M | 27.59M | -11.94M | -87.40M | -80.93M | -57.24M | -51.90M | -86.97M | -117.33M | 125.66M |
| Net Income growth (YoY) | -78.75% | — | — | — | — | — | — | — | -193.37% | — |
| Depreciation & Amortization | 12.28M | 7.37M | 4.54M | 3.33M | 1.99M | 2.15M | 972.00K | 2.86M | 1.80M | 2.40M |
| Stock-Based Compensation | 24.20M | 21.36M | 17.65M | 13.45M | 12.20M | 6.51M | 6.20M | 6.86M | 4.85M | 5.13M |
| Change in Working Capital | -38.27M | -22.21M | 29.25M | 6.19M | -18.19M | -6.91M | -7.91M | 40.92M | -2.18M | -10.97M |
| Operating Cash Flow | 18.25M | 42.51M | 34.09M | -80.68M | -61.71M | -28.13M | -88.48M | -37.73M | -64.78M | -78.09M |
| Capital Expenditures | -4.57M | -9.69M | -42.44M | -7.59M | -11.47M | -801.00K | -2.56M | -354.00K | — | -1.14M |
| Investing Cash Flow | -304.80M | -96.65M | -1.99M | 4.87M | -151.54M | 15.22M | -22.84M | -234.00K | 16.68M | -1.13M |
| Debt Issued | 325.00M | — | — | — | — | 4.87M | — | — | — | — |
| Financing Cash Flow | 315.10M | -137.27M | 136.61M | 21.39M | 270.27M | 49.85M | 69.86M | 61.29M | 73.56M | 43.04M |
| Net Change in Cash | 28.55M | -191.40M | 168.71M | -54.42M | 57.02M | 36.94M | -41.46M | 23.33M | 25.46M | -36.18M |
| Free Cash Flow | 13.69M | 32.82M | -8.35M | -88.27M | -73.17M | -28.93M | -91.05M | -38.09M | -64.78M | -79.23M |
This table shows 10 annual periods of MannKind's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MNKD's reporting calendar. What is a cash flow statement?